Cline Christopher R.
CIK 0001943192
Chief Financial Officer
Filings
21
Latest May 6, 2026
Issuers covered
1
Showing
21 of 21
Page 1
Track record
26 of 27 open-market trades scored (96% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 26 | 38% | -5.7% | -2.8% | +44.3% | -51.5% |
| 90 days | 21 | 48% | -15.2% | -5.9% | +55.7% | -106.5% |
| 180 days | 18 | 39% | -19.5% | -20.0% | +66.1% | -127.4% |
| 365 days | 14 | 36% | -43.1% | -65.3% | +68.2% | -137.9% |
Issuers
Companies where Cline Christopher R. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 21 | May 6, 2026 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|